iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
1.180
+0.014 (1.20%)
At close: Aug 15, 2025, 4:00 PM
1.220
+0.040 (3.39%)
After-hours: Aug 15, 2025, 7:52 PM EDT
iSpecimen Revenue
iSpecimen had revenue of $713.14K in the quarter ending June 30, 2025, a decrease of -75.10%. This brings the company's revenue in the last twelve months to $5.91M, down -43.77% year-over-year. In the year 2024, iSpecimen had annual revenue of $9.29M, down -6.42%.
Revenue (ttm)
$5.91M
Revenue Growth
-43.77%
P/S Ratio
0.33
Revenue / Employee
$246,170
Employees
24
Market Cap
6.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.29M | -637.07K | -6.42% |
| Dec 31, 2023 | 9.93M | -474.12K | -4.56% |
| Dec 31, 2022 | 10.40M | -733.00K | -6.58% |
| Dec 31, 2021 | 11.14M | 2.95M | 36.06% |
| Dec 31, 2020 | 8.18M | 3.89M | 90.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
ISPC News
- 10 days ago - iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow - Newsfile Corp
- 13 days ago - iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market - GlobeNewsWire
- 17 days ago - iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market - GlobeNewsWire
- 20 days ago - Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering - GlobeNewsWire
- 20 days ago - Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering - GlobeNewsWire
- 23 days ago - iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering - GlobeNewsWire
- 24 days ago - iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering - GlobeNewsWire
- 7 months ago - iSpecimen Secures Suppliers for COVID-style hMPV Outbreak - Newsfile Corp